Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc. | Director | Stock Options | 147K | $382K | $2.60 | Jun 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRDF | Cardiff Oncology, Inc. | Jun 27, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
CRDF | Cardiff Oncology, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
CRDF | Cardiff Oncology, Inc. | Sep 19, 2022 | 1 | $24.5K | 4 | Sep 20, 2022 | Director |
CRDF | Cardiff Oncology, Inc. | Jul 5, 2022 | 2 | $0 | 4 | Jul 6, 2022 | Director |
CRDF | Cardiff Oncology, Inc. | Mar 9, 2022 | 1 | $0 | 4 | Mar 10, 2022 | Director |
OABI | Avista Public Acquisition Corp. II | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | Director |
CRDF | Cardiff Oncology, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |